Time Partners closes £30M venture fund to back life sciences startups
Time Partners Limited has announced the final closing of its first advised fund, Time Boost…
28/06/2022 - 2 minutes
What’s new
Companies unite to bolster diagnostics for cancer and liver disease
Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…
28/06/2022 - 2 minutes
Breast cancer drug recommended for approval
A cancer drug from AstraZeneca and Daiichi Sankyo called Enhertu, that reduces the risk of…
28/06/2022 - 3 minutes
MRM Health starts pouchitis clinical trial
MRM Health, a Belgian clinical-stage biopharmaceutical company, has received regulatory approval from the Federal Agency…
28/06/2022 - 3 minutes
Trinity, St. James’s and Legend Biotech collaborating on solid tumors
Trinity College and St. James’s Hospital Dublin (SJH) in Ireland have entered into a strategic…
28/06/2022 - 3 minutes
Eiger BioPharmaceuticals presents liver study data
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharma company focused on the development of innovative therapies to…
28/06/2022 - 4 minutes
Micropep raises €8.75M to develop alternative crop-protection products
French ag-biotech company Micropep, which develops biological micropeptide-based solutions for agriculture, has completed an €8.75…
28/06/2022 - 3 minutes
Biogen, citing insurance challenges, shutters one of its Aduhelm studies
A company says it was forced to end an observational trial of Alzheimer’s drug, Aduhelm,…
28/06/2022 - 3 minutes
Chimerix awarded $25.3M Public Health Agency of Canada deal for smallpox drug
Biopharma firm Chimerix has announced the Public Health Agency of Canada has awarded the company…
27/06/2022 - 2 minutes
OneThree Biotech completes build and optimization of AI model for RSV data
Poolbeg Pharma, a clinical stage infectious disease pharmaceutical company, says its artificial intelligence (AI) partner,…
27/06/2022 - 4 minutes
Eye inflammation leads to FDA partial clinical hold on Nuvation Bio solid tumor study
U.S. biopharma company Nuvation Bio Inc. says the Food and Drug Administration (FDA) has placed…
27/06/2022 - 2 minutes
Chinese biotech company gets go-ahead for mRNA COVID-19 omicron trial in the Philippines
Jiangsu Recbio Technology Co., Ltd. has received clinical trial approval for R520A, a mRNA COVID-19…
27/06/2022 - 1 minute
